Screener
Climb Bio, Inc. CLYM Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $860 | $2,269 |
| Accrued expenses and other current liabilities | 2,948 | 4,459 |
| Operating lease liabilities | 263 | 256 |
| Total current liabilities | 4,071 | 6,984 |
| Operating lease liabilities, net of current portion | 216 | 285 |
| Total liabilities | 4,287 | 7,269 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s accrued expenses?
- Climb Bio, Inc. (CLYM) reported accrued expenses of $2.95M in Q1 2026.
- How has Climb Bio, Inc.'s accrued expenses changed year-over-year?
- Climb Bio, Inc.'s accrued expenses decreased by 51.7% year-over-year, from $6.1M to $2.95M.
- What is the long-term trend for Climb Bio, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s accrued expenses has grown at a 29.6% compound annual growth rate (CAGR), from $1.22M to $4.46M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Climb Bio, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude